Showing results (1611-1620 of 2,220) with videos related to

Sort By:
Pageof 222
Soft Matter|August 8, 2019
Self-diffusion of a highly concentrated monoclonal antibody by fluorescence correlation spectroscopy: insight into protein-protein interactions and self-associationJessica J Hung, Wade F Zeno, Amjad A Chowdhury, et al.
International Journal of Cardiology|November 24, 2012
Drug adherence and the incidence of coronary heart disease- and stroke-specific mortality among 218,047 patients newly prescribed an antihypertensive medication: a five-year cohort studyMartin C S Wong, Wilson W S Tam, Clement S K Cheung, et al.
Stem Cell Reviews and Reports|December 2, 2010
In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cellsSveva Bollini, Michela Pozzobon, Muriel Nobles, et al.
European Heart Journal|July 2, 2019
Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trialPranav S Garimella, Alexandra K Lee, Walter T Ambrosius, et al.
Hepatology (Baltimore, Md.)|March 25, 2022
Risk of liver-related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver diseaseXinrong Zhang, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip, et al.
Mbio|February 7, 2013
Structural and functional analysis of the pore-forming toxin NetB from Clostridium perfringensXu-Xia Yan, Corrine J Porter, Simon P Hardy, et al.
Research Square|June 19, 2023
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): Study protocol for an adaptive randomized controlled trialJesse E Ross, Rubeshan Perumal, Allison Wolf, et al.
Science Advances|June 19, 2026
Architecture and function of holocentric CENP-A-independent inner kinetochoresChristine Yu, Sundar Ram Sankaranarayanan, Gaetan Cornilleau, et al.
Trials|December 1, 2023
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trialJesse Ross, Rubeshan Perumal, Allison Wolf, et al.
Journal of the American Society of Nephrology : JASN|August 16, 2022
Markers of Kidney Tubular Secretion and Risk of Adverse Events in SPRINT Participants with CKDAlexander L Bullen, Simon B Ascher, Rebecca Scherzer, et al.
Pageof 222